A detailed history of High Vista Strategies LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 62,192 shares of AXSM stock, worth $5.6 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
62,192
Previous 48,527 28.16%
Holding current value
$5.6 Million
Previous $3.87 Million 29.29%
% of portfolio
2.01%
Previous 1.53%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$65.72 - $80.5 $898,063 - $1.1 Million
13,665 Added 28.16%
62,192 $5.01 Million
Q1 2024

May 15, 2024

SELL
$69.39 - $97.64 $953,141 - $1.34 Million
-13,736 Reduced 22.06%
48,527 $3.87 Million
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $304,268 - $443,049
5,299 Added 9.3%
62,263 $4.96 Million
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $523,807 - $621,836
7,564 Added 15.31%
56,964 $3.98 Million
Q2 2023

Aug 14, 2023

SELL
$58.41 - $90.35 $664,355 - $1.03 Million
-11,374 Reduced 18.72%
49,400 $3.55 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $329,903 - $423,750
5,650 Added 10.25%
60,774 $3.75 Million
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $1.53 Million - $3.05 Million
38,238 Added 226.45%
55,124 $4.25 Million
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $608,909 - $1.18 Million
16,886 New
16,886 $753,000
Q2 2021

Aug 16, 2021

SELL
$50.63 - $73.5 $590,548 - $857,304
-11,664 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$55.91 - $81.44 $36,397 - $53,017
651 Added 5.91%
11,664 $660,000
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $331,616 - $432,686
5,001 Added 83.18%
11,013 $897,000
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $63,487 - $79,745
-929 Reduced 13.38%
6,012 $428,000
Q2 2020

Aug 14, 2020

BUY
$49.87 - $98.69 $346,147 - $685,007
6,941 New
6,941 $571,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.86B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.